glucose, (beta-d)-isomer has been researched along with Blood Pressure, Low in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 6 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dézsi, L; Fülöp, TG; Hamar, P; Hennies, M; Mészáros, T; Őrfi, E; Rosivall, L; Szebeni, J; Szénási, G | 1 |
| Buharalioglu, CK; Cil, M; Guden, DS; Korkmaz, B; Malik, KU; Sahan-Firat, S; Sari, AN; Senol, SP; Temiz-Resitoglu, M; Tunctan, B; Unsal, D | 1 |
| Hsueh, W; Sun, XM; Torre-Amione, G | 1 |
| Girerd, N | 1 |
| Anker, SD; Brueckmann, M; Butler, J; Dhingra, NK; Ferreira, JP; Filippatos, G; Januzzi, JL; Lam, CSP; Nordaby, M; Packer, M; Peil, B; Pocock, SJ; Sattar, N; Verma, S; Zannad, F | 1 |
| Cheng, L; Fan, Y; Fu, Q; Lin, W; Liu, F; Wu, X; Zhang, X; Zhou, L | 1 |
| Hao, Z; Zhang, Y | 1 |
| Nakade, J; Nakamura, M; Okajima, M; Taniguchi, T; Toyama, T | 1 |
| Aaron, M; Collins, SP; Cox, ZL; Davidson, BT; Fowler, M; Hernandez, GA; Iii, ATM; Jenkins, CA; Jr, FEH; Kampe, C; Lindenfeld, J; Lindsell, CJ; Miller, KF; Stubblefield, WB | 1 |
| Qin, W; Sheng, C; Wang, CH; Yu, YH; Zhao, KS | 1 |
| Barriocanal, LA; Benitez, G; Benitez, S; Jimenez, JT; Jimenez, N; Palacios, M; Rojas, V | 1 |
| Cheng, JT; Hsu, FL; Wang, CJ | 1 |
4 trial(s) available for glucose, (beta-d)-isomer and Blood Pressure, Low
| Article | Year |
|---|---|
Effect of SGLT-2 inhibitor, empagliflozin, on blood pressure reduction in Chinese elderly hypertension patients with type 2 diabetes and its possible mechanisms.
Topics: Aged; Benzhydryl Compounds; Blood Pressure; China; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosides; Humans; Hypertension; Hypotension; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2022 |
Different Doses of Empagliflozin in Patients with Heart Failure with Reduced Ejection Fraction.
Topics: Acute Kidney Injury; Benzhydryl Compounds; Glucosides; Heart Failure; Humans; Hypotension; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 2022 |
Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial.
Topics: Acute Disease; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Disease Progression; Glucosides; Heart Failure; Hospital Mortality; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Hypotension; Hypovolemia; Insulin; Natriuresis; Natriuretic Peptide, Brain; Patient Readmission; Peptide Fragments; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Weight Loss | 2021 |
Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in Type 1 and Type 2 diabetics.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diterpenes, Kaurane; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glucosides; Glycated Hemoglobin; Humans; Hypotension; Insulin; Male; Middle Aged; Pilot Projects; Sweetening Agents | 2008 |
8 other study(ies) available for glucose, (beta-d)-isomer and Blood Pressure, Low
| Article | Year |
|---|---|
Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy.
Topics: Amphotericin B; Animals; Cholesterol; Complement Activation; Complement C3-C5 Convertases; Complement System Proteins; Drug Hypersensitivity Syndrome; Elapid Venoms; Humans; Hypotension; Leukocytosis; Leukopenia; Liposomes; Nanoparticles; Polyethylene Glycols; Rats; Thrombocytopenia; Zymosan | 2019 |
NF-κB activation mediates LPS-or zymosan-induced hypotension and inflammation reversed by BAY61-3606, a selective Syk inhibitor, in rat models of septic and non-septic shock.
Topics: Animals; Cyclooxygenase 2; Disease Models, Animal; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Hypotension; Inflammation; Interleukin-8; Lipopolysaccharides; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Niacinamide; Nitric Oxide Synthase Type II; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Wistar; Shock, Septic; Syk Kinase; Tumor Necrosis Factor-alpha; Zymosan | 2019 |
Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor.
Topics: Animals; BCG Vaccine; Endotoxins; Gastrointestinal Diseases; Hypotension; Lipopolysaccharides; Platelet Activating Factor; Quinolinium Compounds; Rats; Rats, Inbred Strains; Shock, Septic; Tumor Necrosis Factor-alpha; Zymosan | 1990 |
Low Blood Pressure and Managing Drugs in HF: Where Do SGLT2 Inhibitors Stand?
Topics: Benzhydryl Compounds; Glucosides; Humans; Hypotension; Pharmaceutical Preparations; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzhydryl Compounds; Double-Blind Method; Female; Glucosides; Heart Failure; Humans; Hypotension; Male; Stroke Volume | 2022 |
Severe intoxication caused by sodium-glucose cotransporter 2 inhibitor overdose: a case report.
Topics: Adult; Drug Overdose; Female; Glucosides; Humans; Hypotension; Kidney; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2020 |
Hypotensive resuscitation combined with polydatin improve microcirculation and survival in a rabbit model of uncontrolled hemorrhagic shock in pregnancy.
Topics: Animals; Blood Gas Analysis; Blood Pressure; Combined Modality Therapy; Drugs, Chinese Herbal; Female; Glucosides; Hematocrit; Hypotension; Microcirculation; Models, Animal; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy, Animal; Rabbits; Resuscitation; Shock, Hemorrhagic; Stilbenes; Survival Rate | 2011 |
Paeoniflorin reverses guanethidine-induced hypotension via activation of central adenosine A1 receptors in Wistar rats.
Topics: Adrenergic Agents; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Blood Pressure; Bridged-Ring Compounds; Dose-Response Relationship, Drug; Glucosides; Guanethidine; Hypotension; Male; Monoterpenes; Plants, Medicinal; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Xanthines | 1999 |